Malignant Hyperthermia is an uncommon pharmacogenetic disorder of skeletal muscle. It has autosomal dominant inheritance with an incidence of approximately 1:40,000 anaesthetics administered in adults and 1:15,000 in children.
Malignant Hyperthermia (MH) is an inherited disorder of skeletal muscle affecting both males and females.
....
Genetic testing can be defined as an analysis or test that confirms the presence or the absence of a genetic condition.
....
Malignant Hyperthermia contact details and staff.
....
Links to more information about Malignant Hyperthermia.
....
Latest Malignant Hyperthermia news, updates and numbers of patients investigated.
....
The condition arises only after exposure of susceptible individuals to triggering drugs.
....
Malignant Hyperthermia pamphlets and brochures available for download are in Acrobat Reader format.
....
Malignant Hyperthermia databases held by Palmerston North Hospital Anaesthestics Department.
....
Information about Malignant Hyperthermia specialities such as Malignant Hyperthermia in childbirth.
....
A collaborative research project was begun in 1994 between the Department of Anaesthesia and Intensive Care, Palmerston North Hospital, and the Institute of Molecular BioSciences, Massey University, Palmerston North.
....
The Malignant Hyperthermia (MH) anaesthetic technician has an important role in screening for MH susceptible patients and in the maintenance of equipment related to MH.
....